Nurse well-being When Health Care Is Woven in Our Family Fabric, We Find Support in Unexpected Places March 07, 2024
nursing professional development OCN® Certification Test-Taking Tips to Ease Your Anxiety February 15, 2024
Oncology nurse-patient relationship Oncology Nurses Help Patient Find Her Music Again December 22, 2023
Interprofessional teams Holiday Traditions Contribute to a Positive Workplace Culture December 15, 2023
Nurse well-being ONS Members Tell Us About the Inspirational Nurses Who’ve Shaped Their Careers November 23, 2023
Trending Topics Research Safety COVID-19 Drug Reference Sheets Specific Populations ONS Congress Newscast View All Topics
Oncology drug research FDA Approves Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma June 23, 2020
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Tazemetostat for Follicular Lymphoma June 19, 2020
Chemotherapy Polypharmacy Before Cancer Is Predictive of Post-Treatment Hospitalization June 19, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Pembrolizumab for Patients With TMB-H Solid Tumors June 17, 2020
U.S. Food and Drug Administration (FDA) FDA Extends Indication for Gemtuzumab Ozogamicin for CD33-Positive AML in Pediatric Patients June 16, 2020
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Lurbinectedin for Metastatic Small Cell Lung Cancer June 16, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Nivolumab for Esophageal Squamous Cell Carcinoma June 11, 2020
Press Releases ONS Virtual Conference Bridges the Gap Between Education and Practice Change June 10, 2020
Clinical practice Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations June 09, 2020
ONS Leadership For 2021, ONS Election Recruitment Goes Virtual, Congress Fees Remain Level June 08, 2020
Oncology drug research FDA Approves Ramucirumab Plus Erlotinib for First-Line Treatment of Metastatic NSCLC June 01, 2020
Oncology drug research FDA Approves Nivolumab Plus Ipilimumab and Chemotherapy for First-Line Treatment of Metastatic NSCLC May 27, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Brigatinib for ALK-Positive, Metastatic NSCLC May 26, 2020
Oncology drug research FDA Approves Olaparib for HRR Gene-Mutated, Metastatic, Castration-Resistant Prostate Cancer May 20, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Atezolizumab for First-Line Treatment of Metastatic NSCLC With High PD-L1 Expression May 19, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Ripretinib for Advanced Gastrointestinal Stromal Tumor May 18, 2020
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Rucaparib for BRCA-Mutated, Metastatic, Castration-Resistant Prostate Cancer May 18, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Nivolumab Plus Ipilimumab for First-Line Metastatic Non-Small Cell Lung Cancer May 18, 2020
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Pomalidomide for Kaposi Sarcoma May 15, 2020
Genetics & genomics Family Risk Factors May Indicate Need for Genetics Counseling Referrals May 14, 2020
Clinical practice COVID-19 Talking Points for Patients With Cancer, Caregivers, and Family Members May 12, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Olaparib Plus Bevacizumab as Maintenance Treatment for Ovarian, Fallopian Tube, or Primary Peritoneal Cancers May 12, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Selpercatinib for Lung and Thyroid Cancers With RET Gene Mutations or Fusions May 12, 2020
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Capmatinib for Metastatic Non-Small Cell Lung Cancer May 07, 2020
Cancer health disparities Nurses Address Barriers to Care Through CoC’s Revised Standards May 07, 2020